Artificial Cell Technologies, Inc. Company Profile

04:37 EST 15th December 2018 | BioPortfolio

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypeptides. Our long term vision is to commercialize biotechnology applications for successively more sophisticated versions of an artificial bionanomachine: the artificial cell. ACT was founded to achieve this artificial cell vision by commercializing biomedical applications of our proprietary polypeptide nanostructure technology platform, starting with one of the simplest of human cells, the red blood cell. ACT’s technology platform includes proprietary methods for manufacturing custom-designed polypeptide films and microcapsules with controlled, tunable biological, chemical, and physical properties.


5 Science Park Suite 13
New Haven
United States of America


Phone: 203-772-3430
Fax: 203-567-8073

News Articles [2088 Associated News Articles listed on BioPortfolio]

New artificial cell successfully minimised to target and kill specific bacteria.

An artificial cell is a bioengineered particle which mimics a naturally occuring biological cell. The hypothesis is that the synthetic biologic biomimics some of the properties of cells, such as surfa...

Most lifelike synthetic eukaryotic cells manufactured yet.

In synthetic biology an artificial cell or minimal cell is an engineered particle which mimics one or many functions of a biological cell. The theory behind these highly desirable synthetic entities i...

China and Israel Are Ready to Battle: Who Leads the Medical Imaging Artificial Intelligence Market?

In October 2017, China’s State Council laid out a plan to develop a domestic artificial intelligence (AI) industry worth $150 billion by 2030, with the aim of becoming a global leader in AI technolo...

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims ...

Scientists Generate Key Life Event in Artificial Mouse 'Embryo' Created from Stem Cells

NewsThe creation of artificial embryos has moved a step forward after an international team of researchers used mouse stem cells to produce artificial embryo-like structures capable of 'gastrulation,'...

Shanghai Cell Therapy Closes $40 Million C1 Round for Cancer Drugs

Shanghai Cell Therapy completed a $40 million Series C1 financing, led by China Industrial Asset Management, which contributed $26 million of the total. Shanghai Cell Therapy is developing oncology dr...

Cancer Cells Distinguished By Artificial Intelligence-Based System

NewsOsaka University researchers have developed a system using artificial intelligence that can automatically differentiate between different types of cancer cell.

PubMed Articles [3601 Associated PubMed Articles listed on BioPortfolio]

Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan.

Low birth rates and infertility are growing concerns for many countries. The Artificial Reproduction Act (ARA) was implemented in 2007 to better support the use of assisted reproductive technology (AR...

Artificial Methods for T Cell Activation: Critical Tools in T Cell Biology and T Cell Immunotherapy.

Antigen-specific immunity conferred by T lymphocytes is a result of complex molecular interactions at the immunological synapse. A variety of biomimetic approaches have been devised to artificially in...

Topography design in model membranes: Where biology meets physics.

Artificial membranes with complex topography aid the understanding of biological processes where membrane geometry plays a key regulatory role. In this review, we highlight how emerging material and e...

An artificial intelligent single cell is part of the cell dream world.

Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promoters.

Bidirectional promoters (BPs) are prevalent in eukaryotic genomes. However, it is poorly understood how the cell integrates different epigenomic information, such as transcription factor (TF) binding ...

Clinical Trials [7390 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Artificial Shrinkage for Human Blastocyst Prior Vitrification

Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located ...

Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma is one of the most common malignant tumor of upper digestive tract. However, the detection rate and diagnosis accuracy of early esophageal squamous cell ...

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

The purpose of this study is to assess and compare the safetyness and efficacy of pilocarpine drops versus artificial saliva as symptomatic treatment for dry mouth and dry eyes caused by...

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Companies [2396 Associated Companies listed on BioPortfolio]

Artificial Cell Technologies, Inc.

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypep...

Kurzweil Technologies, Inc.

Kurzweil Technologies, Inc. (KTI) is a research and development company developing and marketing technologies in pattern recognition, artificial intelligence, evolutionary algorithms, signal processin...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artifici...

Guava Technologies, Inc

Guava Technologies is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. The company has ISO13485 certificati...

More Information about "Artificial Cell Technologies, Inc." on BioPortfolio

We have published hundreds of Artificial Cell Technologies, Inc. news stories on BioPortfolio along with dozens of Artificial Cell Technologies, Inc. Clinical Trials and PubMed Articles about Artificial Cell Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Artificial Cell Technologies, Inc. Companies in our database. You can also find out about relevant Artificial Cell Technologies, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Nanotechnology is the engineering of functional systems at the molecular scale. This covers both current work and concepts that are more advanced.  In its original sense, 'nanotechnology' refers to the projected ability to construct items fr...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record